Variant Summary
- HGVS
- —
- Variant Type(s)
- —
- Evidence Items
- 4
Evidence Level Distribution
Level B: 2Level D: 2
Evidence Items
Showing CIViC evidence rows where gene = GNAQ and variant = Mutation.
| Level | Type | Direction | Significance | Disease | Drugs | Rating |
|---|---|---|---|---|---|---|
| D | Predictive | Supports | Sensitivity/Response | Uveal Melanoma | Mirdametinib,Sotrastaurin Acetate | 4 |
| D | Predictive | Supports | Sensitivity/Response | Uveal Melanoma | JQ1 | 2 |
| B | Predictive | Supports | Sensitivity/Response | Uveal Melanoma | Trametinib | 2 |
| B | Predictive | Supports | Sensitivity/Response | Uveal Melanoma | Cabozantinib | 2 |